RAVULIZUMAB

Clinical Indication

Treating atypical haemolytic uremic syndrome (aHUS)

Comments

Only for use in specialist centres (which are not in LLR at present) as per NICE TA710.

Date of classification

September 2021

Review date

September 2021

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.